News
-
R&D
C4U and Sumitomo Dainippon Pharma enter into the Next Stage of Joint Research
-
Alliance
C4U, the Division of Animal Genetics, the Institute of Medical Science, the University of Tokyo and Transgenic Inc. have entered into the joint research agreement for genome editing experiments using mouse model with humanized exon.
-
Information
C4U has been awarded the “JHVS2021 Venture Award” as a result of the “90-second elevator pitch” at the “Japan Healthcare Venture Summit 2021” held on October 13-15, 2021.
-
Alliance
C4U enters into Non-Exclusive Sublicense Agreement with Nippon Gene
-
IP
The patent for the invention, “A method for detecting specific DNA in the sample”, was issued by Japan Patent Office.Patent registration number: No. 6940086
-
IP
The patent for the invention, “GENOME EDITING METHOD”, was issued by Japan Patent Office.Patent registration number: No. 6948718
-
Information
C4U will participate in BIO JAPAN at PACIFICO Yokohama (JHVS booth V-44).Our CEO Hirai will give a presentation at the pitch event on October 14, 2021 at 2pm.
-
Alliance
C4U enters into Non-Exclusive Sublicense Agreement with iPS Portal
-
Alliance
C4U and National Center for Child Health and Development Started Joint Research
-
Media
C4U has raised $8.5 million (930 million yen) in Series A funding by the end of July.